Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorandil for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer
NCT07897409Phase 2Not yet recruiting
- Sponsor
- Universiti Sains Malaysia
- Start
- Dec 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of nicorandil in Cardiotoxicity, sponsored by Universiti Sains Malaysia. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
nicorandil
03
Conditions
Cardiotoxicity
Beyond the preview
Go deeper on NCT07897409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07897409.